Investigative Site — Omaha, Nebraska

Investigative Site is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Investigative Site has participated in 9 clinical trials with 1 currently active.

Therapeutic areas: Cancer Weight Loss, AIS, Constipation.

Sponsors: Endevica Bio, CSPC-NBP Pharmaceutical Co., Ltd., Novartis.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Site?

Investigative Site has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Site conducted?

Investigative Site has 9 clinical trials on record, with 1 currently active. Their work covers Cancer Weight Loss, AIS, Constipation.

Is Investigative Site accredited by Crixeo Health?

Yes — Investigative Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.